Potential for CsA-Neoral in organ transplantation.
Levy
G
G
Toronto Hospital-University, Ontario, Canada.
Grant
D
D
D000284:Administration, Oral; D000328:Adult; D002648:Child; D002779:Cholestasis / Q000150:complications; D016572:Cyclosporine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006084:Graft Rejection / Q000188:drug therapy; D016027:Heart Transplantation / Q000276:immunology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D014181:Transplantation Immunology
D016572:Cyclosporine